Preparation for the prophylaxis of restenosis
First Claim
1. A composition of matter comprising a pharmaceutically effective amount of taxol or a tumor-active analog thereof, solubilized in a pharmaceutically acceptable carrier comprising an oil having a dipole moment of between about 0.5 Debyes and about 2.0 Debyes.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected sections of the vascular walls as higher doses cause undesirable side effects. The present invention is a preparation to which at least one antihyperplastic agent is added that has a distribution ratio between butanol and water ≧0.5. The lipophilic active agent is absorbed by the vascular wall fast and in sufficient quantity. The preparation may be a liquid that can pass through capillaries and may contain a contrast agent so that the active agent is transferred into the vascular wall without any additional effort while the usually required contrast radiograms are taken. The preparation may also be applied to a catheter.
188 Citations
18 Claims
- 1. A composition of matter comprising a pharmaceutically effective amount of taxol or a tumor-active analog thereof, solubilized in a pharmaceutically acceptable carrier comprising an oil having a dipole moment of between about 0.5 Debyes and about 2.0 Debyes.
- 8. A composition of matter comprising a pharmaceutically effective amount of taxol solubilized in an oil selected from the group consisting of orange roughy oil, shark liver oil, squalane and squalene.
- 10. A composition of matter comprising an oil having a dipole moment of between about 0.5 Debyes and about 2.0 Debyes in which taxol or a tumor-active analog thereof is solubilized in said oil at a level greater than or equal to 1 mg/ml.
-
13. A method for solubilizing taxol or a tumor-active taxol analog in a pharmaceutically acceptable carrier comprising:
-
(a) solubilizing taxol or said taxol analog in an anhydrous alcohol;
(b) mixing the solution of (a) with a sufficient amount of a pharmaceutically acceptable carrier comprising an oil having a dipole moment of between about 0.5 Debyes and about 2.0 Debyes, to solubilize said solution. - View Dependent Claims (14, 15, 16, 17)
-
Specification